Induction and augmentation of labor in hypertensive patients with intravenous prostaglandin E2.
Labor was successfully induced or stimulated with intravenous Prostaglandin E2 (0.1-2.0 microgram/min) in a group of twenty-nine hypertensive gravidae at 36-41 weeks' gestation. No adverse maternal or perinatal effects of the drug were recorded.